These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 22155539)

  • 1. Advances in human proteomics at high scale with the SOMAscan proteomics platform.
    Gold L; Walker JJ; Wilcox SK; Williams S
    N Biotechnol; 2012 Jun; 29(5):543-9. PubMed ID: 22155539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
    Ray S; Reddy PJ; Jain R; Gollapalli K; Moiyadi A; Srivastava S
    Proteomics; 2011 Jun; 11(11):2139-61. PubMed ID: 21548090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease.
    Yilmaz Y
    Clin Chim Acta; 2012 Aug; 413(15-16):1190-3. PubMed ID: 22546610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics: the next revolution in laboratory medicine?
    Plebani M
    Clin Chim Acta; 2005 Jul; 357(2):113-22. PubMed ID: 15941565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-content affinity-based proteomics: unlocking protein biomarker discovery.
    Brody EN; Gold L; Lawn RM; Walker JJ; Zichi D
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1013-22. PubMed ID: 21080818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
    Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
    Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in blood-related proteomics.
    Thadikkaran L; Siegenthaler MA; Crettaz D; Queloz PA; Schneider P; Tissot JD
    Proteomics; 2005 Aug; 5(12):3019-34. PubMed ID: 16041673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of urinary proteomics in biomarker discovery.
    Shao C; Wang Y; Gao Y
    Sci China Life Sci; 2011 May; 54(5):409-17. PubMed ID: 21455690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.
    Patel S
    Expert Rev Proteomics; 2012 Jun; 9(3):249-65. PubMed ID: 22809205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics, nanotechnology and molecular diagnostics.
    Johnson CJ; Zhukovsky N; Cass AE; Nagy JM
    Proteomics; 2008 Feb; 8(4):715-30. PubMed ID: 18297650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New stationary phases for enrichment and separation in the 'omics' era.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Bioanalysis; 2009 Apr; 1(1):151-69. PubMed ID: 21083194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma-derived microparticles for biomarker discovery.
    Smalley DM; Ley K
    Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of large-scale quantitative shotgun proteomic profiles for biomarker discovery.
    Isserlin R; Emili A
    Curr Opin Mol Ther; 2008 Jun; 10(3):231-42. PubMed ID: 18535930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OMICS-driven biomarker discovery in nutrition and health.
    Kussmann M; Raymond F; Affolter M
    J Biotechnol; 2006 Aug; 124(4):758-87. PubMed ID: 16600411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.